-The New Indian Express NEW DELHI: Amid controversial reports of hunger deaths in Jharkhand due to PDS beneficiaries being turned away, economist Jean Dreze says that even official records show that a significant proportion of people are being deprived of food rations every month. In an interview with New Sunday Express, the prime mover behind the NREGA welfare scheme said “this does not mean that Aadhaar is solely responsible for the failures...
More »SEARCH RESULT
Total Matching Records found : 2128
First-ever Gender Vulnerability Index will give activists tangible parameters to tackle discrimination against Indian women -Deya Bhattacharya
-Firstpost.com The first ever Gender Vulnerability Index (GVI), developed by Plan India, a non-governmental organisation, indicates that Goa is the safest for women and girls while Bihar ranked the lowest for their safety and security. The GVI is a composite index developed for a study for Plan India’s ‘Plan for Every Child’ – a campaign that is targetted at understanding the problems that women and girls face in difficult circumstances. The report...
More »Hungry India: Are we angry enough? -Patralekha Chatterjee
-The Asian Age The fact is that even if India was a few notches higher, it still would be among the severe cases in terms of the magnitude of malnourishment. Do we really trail North Korea and Iraq in the malnutrition stakes? There have been outbursts of anger at India being ranked 100th out 119 countries in the latest edition of the Global Hunger Index by the International Food Policy Research Institute...
More »India shocks with vaccine patent -Latha Jishnu
-Down to Earth Why did we grant Pfizer's claim on a pneumonia vaccine which has been rejected elsewhere? In august, the medical and public health fraternity was stunned when India’s Patent Office granted US pharma giant Pfizer’s claim on its vaccine against pneumonia, the pneumococcal conjugate vaccine (PCV), marketed as Prevnar13. For a country that has stricter patentability criteria than most others, India’s decision was baffling because Pfizer’s patent has been rejected...
More »To market new drugs in India, global trials must include Indians -Sushmi Dey
-The Times of India NEW DELHI: In a move to ensure efficacy of medicines sold in India, the drug regulator has made it mandatory for companies to include Indian patients in global clinical trials if they want to market in India a new drug developed outside the country. The decision was taken in a recent technical committee meeting, headed by director general of health services Jagdish Prasad. The committee, which was formed...
More »
